By Specification (Optimal seeding density, Yield, Stability, Mono layer cyp induction, attachment ef-ficiency and phase 1 and Phase 2 metabolising enzyme), By Application (Clearance metabolic, Stabil-ity, Species comparison studies, Regenerative Medicine Metabolic ID, Metabolic stability and Meta-bolic profiling), By Region (North America, Europe, APAC and Rest of the World)
The liver is an essential part of the human body. Also, liver cells can repair themselves after any damage. Due to this unique ability, liver tissues have fascinated the researchers for scientific experiments. The deep understanding of cellular and molecular connectivity and functioning of lever tissues is very important in the view of the diagnostic and diagnostic applications. Owing to the rising acceptance of these advantages in the medical sector worldwide, the liver cell business size is expected to increase notably in the coming years. One of the major factors driving the liver cell market shares significantly is that these cells are the major components of research and development activities in liver treatments. The liver cells remain isolated from the whole liver system during the process of digestion which makes it easy to study these cells keenly.
Liver cells market revenue is estimated to be $XX Billion in 2022 and shall grow with a CAGR of XX.X% during the forecast period of 2022 to 2031.
The development of liver models provides a virtual ecosystem that mimics the molecular processes of the liver factory. This helps doctors to understand the molecular interaction of whole organ functions more realistically and practically. These are advanced liver models that are estimated to mimic human lever physiology anatomy and molecular layer. However, the highly sensitive nature of these cells can make the research activities quite difficult which in turn is likely to hamper the growth of liver cell market size. Further, the increased blood-brain blockage research activities are anticipated to propel the market revenue significantly over the forecast period.
REGIONAL ANALYSIS:
North America has shown its dominance in terms of revenue in 2022. The rising awareness among people in the region is driving the revenue of the market in North America. The high growth in this region is mainly due to the presence of highly advanced and well-established life sciences industries and growing awareness about organoids technology. The increasing government funding, less availability of livers for transplantation and increasing investments in research are the major liver cell industry trends driving the industry shares. The increasing focus on tissue culture-based clinical diagnostics and the availability of well-trained professionals in this region is one of the major drivers of the market. Further, the Europe region is anticipated to fuel up the market revenue significantly over the forecast period. Moreover, the Asia Pacific region is also anticipated to grow significantly over the forecast period owing to the increasing development of the infrastructure of the medical sector.
SEGMENT ANALYSIS
Based on specifications, the liver cell market research report provides detailed analysis of as optimal seeding density, yield, stability, monolayer cyp induction, attachment efficiency and phase 1 and Phase 2 metabolizing enzyme. Further, based on application, the market has been segmented as clearance metabolic, stability, species comparison studies, regenerative medicine, metabolic ID, metabolic stability and metabolic profiling. Further, the regenerative medicine segment dominated the market in terms of revenue.
INDUSTRY PLAYER ANALYSIS
Major industry players have been analyzed with coverage on their operating areas, revenues, and other strategic aspects. These industry players include Lonza, Cell Biologics, Promo Cell GmbH, Thermo Fisher Scientific, Sigma-Aldrich, Cureline, Zen-Bio, Pelobiotech and Stem cell Technologies. Further, the increasing awareness among the consumers about academics and making a career in a particular field of medical science is going to support industry growth.
COVERAGE HIGHLIGHTS
• Revenue Estimation and Forecast (2022 – 2031)
• Production Estimation and Forecast (2022 – 2031)
• Breakdown of Revenue by Segments (2022 – 2031)
• Breakdown of Production by Segments (2022 – 2031)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
• Regional Analysis and Data Breakdown
SEGMENTAL ANALYSIS:
By Specification Outlook ($Revenue, 2022-2031)
· Optimal seeding density
· Yield
· Stability
· Mono layer cyp induction
· Attachment efficiency
· Phase 1 and Phase 2 metabolizing enzyme activities
By Application Outlook ($Revenue, 2022-2031)
• Clearance metabolic
• Stability
• Regenerative medicine
• Species comparison studies
• Metabolic ID
• Metabolic stability
• Metabolic profiling
By Regional Outlook ($Revenue, 2022-2031)
• North America
• Canada
• U.S
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Rest of the World
• The Middle East and Africa
• Latin America
INDUSTRY PLAYERS ANALYSIS:
· Lonza
· Cell Biologics
· Promo Cell GmbH
· Thermo Fisher Scientific
· Sigma-Aldrich
· Cureline
· Zen-Bio
· Pelobiotech
· Stem cell Technologies
Need Report on a particular Country OR need a Tailored/Customized Research? Budget Limits/Price Discounts Query...!
Email to David Correa
OR Fill the below "Sample Request FORM" with your queries in the message box.
CHAPTER 1: INTRODUCTION
1.1. Research Methodology
1.1.1. Desk Research
1.1.2. Data Synthesis
1.1.3. Data Validation & Market Feedback
1.1.4. Data Sources
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Global Market Outlook
2.2. Core Insights - Specification
2.3. Core Insights – Application
2.4. Core Insights – Geography
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Forces Shaping the Industry
3.2.1. Bargaining Power of Suppliers
3.2.2. Bargaining Power of Buyers
3.2.3. Threat of Substitutes
3.2.4. Threat of New Entrants
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Supply-side Drivers
3.3.1.2. Demand-side Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.4. Industry Landscape - PESTEL Analysis
3.4.1. Political Landscape
3.4.2. Environmental Landscape
3.4.3. Social Landscape
3.4.4. Technology Landscape
3.4.5. Economic Landscape
CHAPTER 4: MARKET BACKGROUND
4.1. Industry Value Chain Analysis
4.1.1. Upstream Participants
4.1.2. Downstream participants
4.2. Pricing Analysis and Forecast, 2018-2026
4.2.1. By Type
4.2.2. By Region
CHAPTER 5: GLOBAL LIVER CELLS MARKET MARKET, BY SPECIFICATION
5.1. Overview
5.1.1. Market Volume and Forecast, 2018-2026
5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026
5.2. Optimal seeding density
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Volume and Forecast, By Region
5.2.3. Market Revenue (US$ Million) and Forecast, By Region
5.3. Yield
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Volume and Forecast, By Region
5.3.3. Market Revenue (US$ Million) and Forecast, By Region
5.4. Stability
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Volume and Forecast, By Region
5.4.3. Market Revenue (US$ Million) and Forecast, By Region
5.5. Mono layer cyp induction
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Volume and Forecast, By Region
5.5.3. Market Revenue (US$ Million) and Forecast, By Region
5.6. Attachment efficiency
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Volume and Forecast, By Region
5.6.3. Market Revenue (US$ Million) and Forecast, By Region
5.7. Phase 1 and Phase 2 metabolizing enzyme activities
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Volume and Forecast, By Region
5.7.3. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 6: GLOBAL LIVER CELLS MARKET MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market Volume and Forecast, 2018-2026
6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026
6.2. Clearance metabolic
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Volume and Forecast, By Region
6.2.3. Market Revenue (US$ Million) and Forecast, By Region
6.3. Stability
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Volume and Forecast, By Region
6.3.3. Market Revenue (US$ Million) and Forecast, By Region
6.4. Regenerative medicine
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Volume and Forecast, By Region
6.4.3. Market Revenue (US$ Million) and Forecast, By Region
6.5. Species comparison studies
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Volume and Forecast, By Region
6.5.3. Market Revenue (US$ Million) and Forecast, By Region
6.6. Metabolic ID
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Volume and Forecast, By Region
6.6.3. Market Revenue (US$ Million) and Forecast, By Region
6.7. Metabolic stability
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Volume and Forecast, By Region
6.7.3. Market Revenue (US$ Million) and Forecast, By Region
6.8. Metabolic profiling
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Volume and Forecast, By Region
6.8.3. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 7: GLOBAL LIVER CELLS MARKET MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Volume and Forecast, By Specification
7.2.3. Market Volume and Forecast, By Application
7.2.4. Market Revenue and Forecast, By Specification
7.2.5. Market Revenue and Forecast, By Application
7.2.6. Market Revenue and Forecast, By Country
7.2.7. U.S.
7.2.7.1. Market Volume and Forecast
7.2.7.2. Market Revenue and Forecast
7.2.8. Canada
7.2.8.1. Market Volume and Forecast
7.2.8.2. Market Revenue and Forecast
7.2.9. Mexico
7.2.9.1. Market Volume and Forecast
7.2.9.2. Market Revenue and Forecast
7.3. Europe
7.3.1. Market Volume and Forecast, By Specification
7.3.2. Market Volume and Forecast, By Application
7.3.3. Market Revenue and Forecast, By Specification
7.3.4. Market Revenue and Forecast, By Application
7.3.5. Market Revenue and Forecast, By Country
7.3.6. Germany
7.3.6.1. Market Volume and Forecast, By Specification
7.3.6.2. Market Revenue and Forecast, By Application
7.3.7. UK
7.3.7.1. Market Volume and Forecast, By Specification
7.3.7.2. Market Revenue and Forecast, By Application
7.3.8. France
7.3.8.1. Market Volume and Forecast, By Specification
7.3.8.2. Market Revenue and Forecast, By Application
7.3.9. Italy
7.3.9.1. Market Volume and Forecast, By Specification
7.3.9.2. Market Revenue and Forecast, By Application
7.3.10. Rest of Europe
7.3.10.1. Market Volume and Forecast, By Specification
7.3.10.2. Market Revenue and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Market Volume and Forecast, By Specification
7.4.2. Market Volume and Forecast, By Application
7.4.3. Market Revenue and Forecast, By Specification
7.4.4. Market Revenue and Forecast, By Application
7.4.5. Market Revenue and Forecast, By Country
7.4.6. China
7.4.6.1. Market Volume and Forecast, By Specification
7.4.6.2. Market Revenue and Forecast, By Application
7.4.7. India
7.4.7.1. Market Volume and Forecast, By Specification
7.4.7.2. Market Revenue and Forecast, By Application
7.4.8. Japan
7.4.8.1. Market Volume and Forecast, By Specification
7.4.8.2. Market Revenue and Forecast, By Application
7.4.9. South Korea
7.4.9.1. Market Volume and Forecast, By Specification
7.4.9.2. Market Revenue and Forecast, By Application
7.4.10. Rest of Asia-Pacific
7.4.10.1. Market Volume and Forecast, By Specification
7.4.10.2. Market Revenue and Forecast, By Application
7.5. REST OF THE WORLD
7.5.1. Market Volume and Forecast, By Specification
7.5.2. Market Volume and Forecast, By Application
7.5.3. Market Revenue and Forecast, By Specification
7.5.4. Market Revenue and Forecast, By Application
7.5.5. Market Revenue and Forecast, By Country
7.5.6. Latin America
7.5.6.1. Market Volume and Forecast, By Specification
7.5.6.2. Market Revenue and Forecast, By Application
7.5.7. Middle East
7.5.7.1. Market Volume and Forecast, By Specification
7.5.7.2. Market Revenue and Forecast, By Application
7.5.8. Africa
7.5.8.1. Market Volume and Forecast, By Specification
7.5.8.2. Market Revenue and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Liver Cells Market Share Analysis, 2018
CHAPTER 9: COMPANY PROFILES
9.1. Lonza
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. SWOT Analysis
9.2. Cell Biologics
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. SWOT Analysis
9.3. Promo Cell GmbH
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. SWOT Analysis
9.4. Thermo Fisher Scientific
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. SWOT Analysis
9.5. Sigma-Aldrich
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. SWOT Analysis
9.6. Cureline
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. SWOT Analysis
9.7. Zen-Bio
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. SWOT Analysis
9.8. Pelobiotech
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. SWOT Analysis
9.9. Stem cell Technologies
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. SWOT Analysis
20% Free Customization ON ALL PURCHASE
*Terms & Conditions Apply
Please fill in the form below to Request for free Sample Report
Office Hours Mon - Sat 10:00 - 16:00
Send Us Mail sales@marketdecipher.com
Market Decipher is a market research and consultancy firm involved in provision of market reports to organisations of varied sizes; small, large and medium.
© 2018 Market Decipher. All Rights Reserved